argenx SE | ARGX - PE Price to Earnings

Stock Price
682.20
Daily Change
-11.00 -1.59%
Monthly
-3.59%
Yearly
34.56%
Q2 Forecast
678.23

argenx SE reported 32.12 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
AstraZeneca 29.59 2.3 Mar/2026
Genmab 17.14 4.39 Dec/2025
GlaxoSmithKline 14.87 3.72 Mar/2026
GRIFOLS 10.98 5.83 Mar/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lakefront Biotherapeutics 2.54 0.6 Mar/2026
Qiagen NV 20.54 0.1 Dec/2025
UCB 29.7 5.52 Dec/2025